Guggenheim Insider Sentiment ETFNFO:PCQ:USD

50.41
0.06 / 0.12%
42.81 - 51.86+1.58
Close in USDToday's change52-week range3-yr sharpe ratio
Data delayed at least 15 minutes, as of Jul 02 2015 20:57 BST.

Objective

The investment seeks investment results that correspond generally to the performance, before the fund's fees and expenses, of an equity index called the Sabrient Insider Sentiment Index. The fund invests at least 90% of its total assets in common stocks, ADRs and MLPs that comprise the index and depositary receipts representing common stocks included in the index. It generally invests in all of the securities comprising the index in proportion to their weightings in the index. The index is comprised of approximately 100 securities selected, based on investment and other criteria, from a broad universe of U.S.-traded securities, including MLPs and ADRs.

Profile

Fund typeOpen Ended Investment Company
Investment style (stocks)
Market Cap: Mid
Investment Style: Blend
Morningstar categoryMid-Cap Blend
Launch date21/09/2006
Price currencyUSD
DomicileUnited States
SymbolNFO
Manager & start date
Michael Byrum
18/12/2013
James King
18/12/2013
Adrian Bachman
29/12/2014

Investment

Total net assets
153.95m USDAs of May 31 2015
Market cap151.28m USD
Shares outstanding3.00m
Average volume (10-day)5.26k
Net expense ratio0.66%
Last dividend0.584 USD
Div yield1.16%
Div ex-date12/24/2014
Div pay-date12/31/2014
Available for saleUnited States

Diversification

Asset type

US stock
99.03%
Non-US stock
0.97%
Cash
0.00%
Other
0.00%
US bond
0.00%
Non-US bond
0.00%

Top 5 sectors

Industrials
17.07%
Consumer Cyclical
15.93%
Financial Services
14.37%
Technology
11.15%
Basic Materials
10.54%

Top 5 Regions

United States
99.03%
United Kingdom
0.97%
Sector and region weightings are calculated using only long position holdings of the portfolio.Sector & regional holdings

Top 5 holdings

Company1 year
change
Portfolio
weight
Long
allocation
Coty Inc Class A
COTY:NYQ
+78.29%1.27%
HCA Holdings Inc
HCA:NYQ
+58.47%1.14%
Ligand Pharmaceuticals Inc
LGND:NMQ
+52.82%1.12%
Blackbaud Inc
BLKB:NSQ
+56.67%1.11%
Enanta Pharmaceuticals Inc
ENTA:NSQ
+1.01%1.10%
Data delayed at least 15 minutes, as of May 29 2015. Top 10 holdings
Intra-day ETF pricing data provided by
© Thomson Reuters Click for restrictions.

The performance data shown in tables and graphs on this page is calculated in USD of the fund / index / average (as applicable), on a Bid To Bid / Nav to Nav basis, with gross dividends re-invested on ex-dividend date. Past performance is not necessarily a guide to future performance; unit prices may fall as well as rise.

All managed funds data located on FT.com is subject to the FT Terms & Conditions . All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2015
All Rights reserved

© 2015 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

The Morningstar Equity Style Box is a unique graphical tool showing a fund’s true investment style and market capitalisation.

The Morningstar Fixed Income Style Box is a unique graphical tool showing a fund's true credit quality and duration.

Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.